Emperion will be owned by Stone Point Capital, Enlyte's current shareholder, through its Trident Funds and a management team led by former Genex executives. The company will bring expanded development opportunities for IME, Peer Review (PR), Independent Review Organization (IRO) and Qualified Medical Examination (QME) services. Emperional will continue to provide its market-leading continuum of technology, medical cost containment, and disability management services and be led by its current management team